On this page:

Enable robust T cell activation with CTS cell therapy reagents

Achieving reproducible and scalable T cell activation can be difficult due to donor variability. Manual isolation steps can influence performance. These factors can affect timing control and create variation in downstream work. Gibco CTS cell therapy reagents allow for more flexible activation approaches. The Gibco CTS Detachable Dynabeads Release Buffer offers active bead detachment to adjust activation timing, while the Gibco CTS Soluble DynActivator CD3/CD28 Reagent supports bead-free activation that can occur independently of isolation steps. Both support T cell activation from development through manufacturing.


Benefits of CTS cell therapy reagents

CTS T cell reagents helps manage timing, bead removal, and activation duration, supporting consistent activation. These product formats fit within closed, automated environments, bridging activation steps to later stages of the workflow. These solutions can be used in autologous and allogeneic settings to support flexible process design.

CTS Detachable Dynabeads Release Buffer

Control T cell activation timing with the CTS Detachable Dynabeads Release Buffer, for adjustable bead detachment when using automated bead-removal workflows on the Gibco CTS DynaCellect Magnetic Separation System.

CTS Soluble DynActivator CD3/CD28​ Reagent

Incorporate bead-free T cell activation with CTS Soluble DynActivator CD3/CD28​ Reagent. It supports activation independently of isolation and can be removed through simple washing or medium exchange.


Optimizing isolation and activation workflows

Designed for closed, automated, and GMP-ready processing


CTS cell therapy reagents are developed to support scale-up from translational and clinical manufacturing needs to commercial manufacturing. Their documentation packages, traceability features, and controlled manufacturing processes are designed to align with GMP expectations and help maintain consistent performance across runs. These attributes make Gibco Cell Therapy Systems (CTS) products well-suited for integration into closed and automated cell therapy workflows.

Support activation control and T cell phenotype preservation


Enhance cell therapy workflows with connected solutions

Integrate Dynabeads cell separation technology with cell therapy products to support consistent handling from isolation through final processing.

Gibco CTS DynaCellect Magnetic Separation System

Automate magnetic separation steps with the CTS DynaCellect Magnetic Separation System, designed to support consistent isolation, activation, and bead removal across T cell workflows.
 

Gibco CTS Rotea Counterflow Centrifugation System

Perform washing, concentration, and separation steps with the CTS Rotea Counterflow Centrifugation System, suited for development and clinical manufacturing.

 

Gibco CTS Xenon Electroporation System

Support closed, scalable transfection with the CTS Xenon Electroporation System, designed for efficient delivery of DNA, RNA, and proteins with strong viability and recovery across development and manufacturing workflows.


Ordering information

N.° de Catálogo Nombre Tamaño Price (MXN) Cantidad
CAA007 Each -

Frequently asked questions

CTS cell therapy reagents support the integral isolation and activation steps of T cell therapy workflows. They are available in both bead-based and bead-free formats, and can be paired with closed, automated systems, such as the CTS DynaCellect Magnetic Separation System for cell isolation and the CTS Rotea Counterflow Centrifugation System for washing and volume reduction.

CTS Detachable Dynabeads Release Buffer uses a biotin-based competitive release mechanism to actively detach CTS Detachable Dynabeads CD3/CD28 beads at your selected timepoint. Excess biotin in the buffer competes with the bead-cell interaction, allowing users to release beads rather than rely on passive dissociation. This approach supports modulation of CD3/CD28 activation strength and duration in both manual and automated workflows. It offers greater flexibility in timing and controlling activation conditions across cell therapy manufacturing steps.

CTS Soluble DynActivator CD3/CD28 Reagent is a soluble reagent that is removed through routine medium exchange or simple washing once the activation window is met. For teams working with closed or larger-scale formats, the CTS Rotea Centrifugation System can handle washing and buffer exchange in a controlled setup. These options make it simple to set defined activation times and move easily into downstream culture or engineering steps.

CTS Detachable Dynabeads Release Buffer should be stored at 2–8°C and kept protected from light. CTS Soluble DynActivator CD3/CD28 Reagent ships frozen and is stored at –15°C to –25°C until use. Each reagent for cell therapy should be handled using standard laboratory protective measures and mixed gently to maintain product integrity. Following these storage and handling guidelines helps keep the reagents ready for use.

Discover cell therapy bioprocessing solutions

Explore cell therapy bioprocessing solutions that help maintain consistency as programs progress from development to manufacturing and adapt to autologous or allogeneic needs.

Cell therapy resources


Explore cell therapy resources for in-depth workflow guidance, application notes, and technical materials that support T cell processing from early development through manufacturing.
 

Advance T cell manufacturing with CTS cell therapy reagents

For Research Use or Manufacturing of Cell, Gene, or Tissue-Based Products. CAUTION: Not intended for direct administration into humans or animals.